Stephens Inc’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,679
Closed -$369K 1326
2024
Q2
$369K Buy
2,679
+121
+5% +$16.7K 0.01% 918
2024
Q1
$353K Sell
2,558
-4,330
-63% -$597K 0.01% 944
2023
Q4
$908K Buy
6,888
+955
+16% +$126K 0.02% 559
2023
Q3
$667K Hold
5,933
0.01% 631
2023
Q2
$559K Buy
5,933
+49
+0.8% +$4.62K 0.01% 703
2023
Q1
$596K Sell
5,884
-166
-3% -$16.8K 0.01% 667
2022
Q4
$723K Hold
6,050
0.01% 586
2022
Q3
$643K Sell
6,050
-84
-1% -$8.93K 0.01% 620
2022
Q2
$598K Buy
6,134
+47
+0.8% +$4.58K 0.01% 667
2022
Q1
$571K Buy
6,087
+561
+10% +$52.6K 0.01% 756
2021
Q4
$471K Sell
5,526
-770
-12% -$65.6K 0.01% 870
2021
Q3
$604K Buy
6,296
+524
+9% +$50.3K 0.01% 801
2021
Q2
$562K Buy
5,772
+116
+2% +$11.3K 0.01% 830
2021
Q1
$550K Buy
+5,656
New +$550K 0.01% 810
2020
Q4
Sell
-5,583
Closed -$537K 1248
2020
Q3
$537K Buy
5,583
+271
+5% +$26.1K 0.01% 714
2020
Q2
$648K Hold
5,312
0.01% 635
2020
Q1
$460K Buy
+5,312
New +$460K 0.01% 669
2019
Q4
Sell
-5,340
Closed -$481K 1182
2019
Q3
$481K Buy
5,340
+840
+19% +$75.7K 0.01% 767
2019
Q2
$380K Hold
4,500
0.01% 832
2019
Q1
$396K Hold
4,500
0.01% 819
2018
Q4
$321K Hold
4,500
0.01% 823
2018
Q3
$553K Buy
+4,500
New +$553K 0.01% 755
2017
Q3
Sell
-4,500
Closed -$207K 813
2017
Q2
$207K Buy
+4,500
New +$207K 0.01% 785
2016
Q4
Sell
-4,500
Closed -$228K 814
2016
Q3
$228K Hold
4,500
0.01% 670
2016
Q2
$205K Buy
+4,500
New +$205K 0.01% 674
2016
Q1
Sell
-5,100
Closed -$289K 782
2015
Q4
$289K Hold
5,100
0.01% 555
2015
Q3
$203K Buy
5,100
+50
+1% +$1.99K 0.01% 645
2015
Q2
$241K Buy
+5,050
New +$241K 0.01% 659